Search for: "JANSSEN PHARMACEUTICALS, INC. "
Results 121 - 140
of 226
Sorted by Relevance
|
Sort by Date
29 Feb 2016, 11:27 pm
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences.Never too late 83 [week ending on Sunday 14 February] – Indigenous IP | Arnold J's latest judgment flags down the iconic London black cab | Life of a national/EU trade mark ... in a map | A comprehensive… [read post]
6 Oct 2010, 11:43 pm
Apotex, Inc., 540 F.3d 1353 (Fed. [read post]
10 Nov 2015, 11:33 am
"] The findings are contrary to data presented [in "New Global Real-World Data from Atrial Fibrillation Studies Confirm the Safety Profile of XARELTO®", a press release from Janssen Pharmaceuticals, Inc.] on the safety of [Xarelto (rivaroxaban)] in 39,052 people with NVAF showed the rates and patterns of major bleeding in routine clinical practice were 2.89 per 100 person-years. [read post]
17 Nov 2015, 5:07 am
Recent articles in Forbes Magazine and The Wall Street Journal reported that Janssen Pharmaceuticals, Inc., which is a Johnson & Johnson company, has been accused of a failure to warn about the side effect. [read post]
21 Jul 2021, 12:44 pm
The manufacturers named in the complaint included Purdue Pharma and its affiliates, as well as members of the Sackler Family (owners of Purdue) and trusts they control; Janssen Pharmaceuticals and its affiliates (including its parent company Johnson & Johnson); Mallinckrodt LLC and its affiliates; Endo Health Solutions and its affiliates; Teva Pharmaceuticals USA, Inc. and its affiliates; and Allergan Finance, LLC and its affiliates. [read post]
16 Jun 2021, 5:20 am
To what extent Janssen Pharmaceuticals was aware of the risk of maculopathy and subsequent vision loss is unclear. [read post]
16 Jun 2021, 5:20 am
To what extent Janssen Pharmaceuticals was aware of the risk of maculopathy and subsequent vision loss is unclear. [read post]
16 Jun 2021, 5:20 am
To what extent Janssen Pharmaceuticals was aware of the risk of maculopathy and subsequent vision loss is unclear. [read post]
7 Oct 2013, 7:12 am
Our next post will discuss the complimentary roles of inside and outside counsel. [1] Dura Pharmaceuticals, Inc. v. [read post]
7 Oct 2013, 7:12 am
Our next post will discuss the complimentary roles of inside and outside counsel. [1] Dura Pharmaceuticals, Inc. v. [read post]
18 Jul 2013, 10:45 am
Ortho-McNeil-Janssen Pharmaceuticals, 2013 WL 3480286 (Pa. [read post]
12 Nov 2014, 10:15 am
Janssen and Teva file to protect Chicago disclosing trade secrets: Back in the summer, the city of Chicago commenced proceedings against several pharmaceutical companies, including Janssen, Purdue Pharma LP, Teva and Actavis alleging that they dishonestly marketed opioid painkillers including Oxycontin and Percocet for the treatment of common and non-cancer related chronic pain resulting in a reported public health crisis of addiction and abuse. [read post]
1 Aug 2008, 12:33 pm
§ 1407 and Transfers Actions to District of Minnesota Fifteen (15) individual and class action lawsuits were filed in seven (7) different federal district courts against Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., and Johnson & Johnson Pharmaceutical Research & Development, among others, alleging “that the antibiotic Levaquin causes tendon rupture, and the warnings provided by defendants informing… [read post]
30 Oct 2018, 4:12 pm
., and Janssen Pharmaceuticals Inc., among others, seeking damages over the opioid crisis. [read post]
26 Dec 2011, 1:02 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. , No. 11-2070 (7th Cir. [read post]
1 Dec 2010, 12:15 am
Abraxis Bioscience, Inc. v. [read post]
5 Mar 2014, 2:46 pm
Wyeth Pharmaceuticals, Inc., Pennsylvania Supreme Court – propriety of punitive damages where defendant compl [read post]
13 Apr 2011, 5:13 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2-10-cv-00836 (E.D. [read post]
7 Feb 2017, 11:58 am
Invokana Janssen Pharmaceuticals paid $20.9 million in payments to doctors promoting the diabetes drug Invokana. [read post]
28 Apr 2015, 9:14 am
Janssen Biotech, Inc. [read post]
